Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.

Revenue
+0.55%
EPS
−85.0%
Free cash flow
+154.2%
Total debt
−4.96%

Quarter to September 2026, against a year earlier

30.43 0.08 −0.26%
Market cap
$29.8B
P/E
25.8×
Fwd P/E
11.2×
Dividend yield
3.33%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100

Koninklijke Philips N.V. (PHG) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a P/S ratio of 1.4×. Over the past ten years it has ranged from 0.4× (November 2022) to 1.9× (September 2018); the current reading is higher than 79% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.3× 4.25%
FY2024 1.2× 45.51%
FY2023 0.8× 48.06%
FY2022 0.6× (54.41%)
FY2021 1.2× (24.53%)
FY2020 1.6× 34.14%
FY2019 1.2× 14.12%
FY2018 1.1× (28.63%)
FY2017 1.5× 59.46%
FY2016 0.9× 9.13%

Quarterly newest first

Period P/S ratio Change
Sep 2026 1.2× (8.20%)
Jun 2026 1.3× (1.05%)
Mar 2026 1.3× 0.28%
Dec 2025 1.3× (6.31%)
37 more quarters

Against its own ten years

Low 0.4× High 1.9×
Ten-year median 1.2×
Current reading's percentile 77

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on PHG